Oramed Receives Warrant for 100,000 Scilex Shares After Deferring Payment

summarizeSummary

Oramed Pharmaceuticals entered into a Warrant Agreement with Scilex Holding Company, receiving a warrant to purchase 100,000 shares of Scilex common stock at a $20.00 exercise price in exchange for deferring an amortization payment.

check_boxKey Events

• Warrant Agreement Signed

  Oramed entered into a Warrant Agreement with Scilex Holding Company on February 19, 2026.

• Warrant Received

  Oramed received a new warrant to purchase 100,000 shares of Scilex common stock.

• Warrant Terms

  The warrant has an initial exercise price of $20.00 per share and an expiration date of December 13, 2029.

• Consideration for Deferral

  The warrant was issued in exchange for Oramed deferring its right to receive an amortization payment from Scilex, which was originally due October 1, 2025, but was subsequently paid in November 2025.

auto_awesomeAnalysis

This 8-K details a new financial agreement where Oramed Pharmaceuticals received a warrant for 100,000 shares of Scilex Holding Company common stock. This warrant, with an exercise price of $20.00, was issued as compensation for Oramed deferring an amortization payment from Scilex, which was later received. This transaction adds a new derivative asset to Oramed's portfolio, providing potential upside exposure to Scilex's stock performance. The agreement also includes provisions for Scilex to register the resale of the underlying shares, facilitating future liquidity for Oramed. This follows recent significant financial activities, including a divestment and a substantial payment, indicating Oramed's active management of its financial assets and strategic relationships.